Comparative study of virus and lymphocyte distribution with clinical data suggests early high dose immunosuppression as potential key factor for the therapy of patients with BoDV-1 infection

Yannik Vollmutha Pathology, Medical Faculty, University of Augsburg, Augsburg, Germany;b Institute of Pathology, School of Medicine and Health, Technical University of Munich, Munich, Germany;c Department of Pediatrics, Dr. von Hauner Children’s Hospital, Ludwig-Maximilians-University Munich, Munich, GermanyView further author information

Nicola Jungbäcka Pathology, Medical Faculty, University of Augsburg, Augsburg, GermanyView further author information

Tatiana Mögelea Pathology, Medical Faculty, University of Augsburg, Augsburg, GermanyView further author information

Friederike Schmidt-Grafd Department of Neurology, Klinikum rechts der Isar, School of Medicine and Health, Technical University of Munich, Munich, GermanyView further author information

Silke Wunderlichd Department of Neurology, Klinikum rechts der Isar, School of Medicine and Health, Technical University of Munich, Munich, GermanyView further author information

Mareike Schimmele Department of Pediatrics and Adolescent Medicine, Medical Faculty, University of Augsburg, Augsburg, GermanyView further author information

Camilla Rothef Division of Infectious Diseases and Tropical Medicine, Ludwig-Maximilians-University Munich, Munich, GermanyView further author information

Leonhard Starkb Institute of Pathology, School of Medicine and Health, Technical University of Munich, Munich, GermanyView further author information

Jürgen Schlegela Pathology, Medical Faculty, University of Augsburg, Augsburg, Germany;b Institute of Pathology, School of Medicine and Health, Technical University of Munich, Munich, GermanyView further author information

Georg Riederg Department of Neurology, InnKlinikum, Altötting, GermanyView further author information

Thomas Richterh Clinic of Pathology, Pathology Rosenheim, Rosenheim, GermanyView further author information

Tina Schallera Pathology, Medical Faculty, University of Augsburg, Augsburg, GermanyView further author information

Dennis Tappei National Laboratory for Bornaviruses, Bernhard Nocht Institute for Tropical Medicine, Hamburg, GermanyView further author information

Bruno Märkla Pathology, Medical Faculty, University of Augsburg, Augsburg, GermanyView further author information

Kaspar Matiasekj Section of Clinical and Comparative Neuropathology, Centre for Clinical Veterinary Medicine, Ludwig-Maximilians-University Munich, Munich, GermanyView further author information

Friederike Liesche-Starneckera Pathology, Medical Faculty, University of Augsburg, Augsburg, GermanyCorrespondence[email protected]

https://orcid.org/0000-0003-1948-1580 View further author information

show all

Comparative study of virus and lymphocyte distribution with clinical data suggests early high dose immunosuppression as potential key factor for the therapy of patients with BoDV-1 infection

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Comparative study of virus and lymphocyte distribution with clinical data suggests early high dose immunosuppression as potential key factor for the therapy of patients with BoDV-1 infection

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date